Literature DB >> 15197074

Central serous chorioretinopathy associated with periocular corticosteroid injection treatment for HLA-B27-associated iritis.

Caroline R Baumal1, Adam Martidis, Steven N Truong.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15197074     DOI: 10.1001/archopht.122.6.926

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


× No keyword cloud information.
  5 in total

Review 1.  Central serous chorioretinopathy: update on pathophysiology and treatment.

Authors:  Benjamin Nicholson; Jason Noble; Farzin Forooghian; Catherine Meyerle
Journal:  Surv Ophthalmol       Date:  2013 Mar-Apr       Impact factor: 6.048

2.  Association between endogenous cortisol level and the risk of central serous chorioretinopathy: a Meta-analysis.

Authors:  Zhi-Qiao Liang; Lyu-Zhen Huang; Jin-Feng Qu; Ming-Wei Zhao
Journal:  Int J Ophthalmol       Date:  2018-02-18       Impact factor: 1.779

3.  Development of Central Serous Chorioretinopathy following Chalazion Removal with Intralesional Triamcinolone Injection: A Case Report.

Authors:  Luca Rosignoli; Stephen Myles Potter; Andres Gonzalez; Sarina Amin; Syed G Khurshid
Journal:  Case Rep Ophthalmol       Date:  2018-09-03

4.  Clinical profile of uveitis patients developing central serous chorioretinopathy: An experience at a tertiary eye care center in India.

Authors:  Parthopratim Dutta Majumder; Nitin Menia; Sridharan Sudharshan; Chetan Rao; Sudha K Ganesh; Jyotirmay Biswas
Journal:  Indian J Ophthalmol       Date:  2019-02       Impact factor: 1.848

Review 5.  Local delivery of corticosteroids in clinical ophthalmology: A review.

Authors:  Adrian T Fung; Tuan Tran; Lyndell L Lim; Chameen Samarawickrama; Jennifer Arnold; Mark Gillies; Caroline Catt; Logan Mitchell; Andrew Symons; Robert Buttery; Lisa Cottee; Krishna Tumuluri; Paul Beaumont
Journal:  Clin Exp Ophthalmol       Date:  2020-01-22       Impact factor: 4.207

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.